Traws Pharma Shuffles Leadership, Appoints New Directors
Ticker: TRAW · Form: 8-K · Filed: Dec 20, 2024 · CIK: 1130598
| Field | Detail |
|---|---|
| Company | Traws Pharma, Inc. (TRAW) |
| Form Type | 8-K |
| Filed Date | Dec 20, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-election, executive-departure
Related Tickers: TRWS
TL;DR
Traws Pharma (TRWS) leadership shakeup: CMO out, new interim CMO and two directors in.
AI Summary
Traws Pharma, Inc. announced on December 16, 2024, the departure of Dr. Steven A. Deitcher as Chief Medical Officer and the appointment of Dr. Richard E. G. Smith as interim Chief Medical Officer. The company also elected Dr. Smith and Ms. Jennifer L. Simpson to its Board of Directors, effective December 16, 2024. These changes are part of the company's ongoing strategic adjustments.
Why It Matters
These executive and board changes could signal a shift in Traws Pharma's strategic direction or operational focus, potentially impacting its drug development pipeline and future performance.
Risk Assessment
Risk Level: medium — Changes in key executive and board positions can introduce uncertainty regarding future strategy and execution, impacting investor confidence.
Key Players & Entities
- Traws Pharma, Inc. (company) — Registrant
- Dr. Steven A. Deitcher (person) — Departing Chief Medical Officer
- Dr. Richard E. G. Smith (person) — Appointed interim Chief Medical Officer and Director
- Ms. Jennifer L. Simpson (person) — Appointed Director
- December 16, 2024 (date) — Effective date of changes
FAQ
Who has departed from Traws Pharma, Inc.?
Dr. Steven A. Deitcher has departed from his role as Chief Medical Officer.
Who has been appointed as the interim Chief Medical Officer?
Dr. Richard E. G. Smith has been appointed as the interim Chief Medical Officer.
When were the changes in leadership and board composition effective?
The changes were effective as of December 16, 2024.
Who were the new directors appointed to the Board?
Dr. Richard E. G. Smith and Ms. Jennifer L. Simpson were elected to the Board of Directors.
What was Traws Pharma, Inc.'s former name?
Traws Pharma, Inc. was formerly known as Onconova Therapeutics, Inc.
Filing Stats: 375 words · 2 min read · ~1 pages · Grade level 11.4 · Accepted 2024-12-20 17:00:35
Filing Documents
- tm2431678d1_8k.htm (8-K) — 23KB
- 0001104659-24-130901.txt ( ) — 189KB
- tmb-20241216.xsd (EX-101.SCH) — 3KB
- tmb-20241216_lab.xml (EX-101.LAB) — 33KB
- tmb-20241216_pre.xml (EX-101.PRE) — 22KB
- tm2431678d1_8k_htm.xml (XML) — 4KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 16, 2024, Luba Greenwood, a member of the Board of Directors (the "Board") of Traws Pharma, Inc. (the "Company"), resigned as a director. Ms. Greenwood's decision was her own and not as a result of any disagreement with the Company. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 20, 2024 TRAWS PHARMA, INC. By: /s/ MARK GUERIN Name: Mark Guerin Title: Chief Financial Officer 2